Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
Active, not recruiting · NCT06082960 · Registry updated 2026-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors | Solid Tumors | Active, not recruiting | Phase 1 | 2026-04-16 | NCT06082960 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NEXT Oncology | San Antonio | United States | 70 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Smilow Cancer Hospital Phase 1 Unit | New Haven | United States | 1 |
| South Texas Accelerated Research Therapeutics, LLC | San Antonio | United States | 8 |
| University Health Network, Princess Margaret Cancer Centre | Toronto | Canada | 1 |